These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18846054)

  • 21. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 22. The dogged scientist, the old lab vial, and the quest to stop cancer.
    Stipp D
    Fortune; 2005 Jun; 151(13):175-6, 178-80, 182, passim. PubMed ID: 15984139
    [No Abstract]   [Full Text] [Related]  

  • 23. The special treatment.
    Osborne R
    Nat Biotechnol; 2008 May; 26(5):487-9. PubMed ID: 18464770
    [No Abstract]   [Full Text] [Related]  

  • 24. Natural compounds show antiangiogenic activity.
    Marwick C
    J Natl Cancer Inst; 2001 Nov; 93(22):1685. PubMed ID: 11717328
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiogenesis inhibitors suffer new setback.
    Garber K
    Nat Biotechnol; 2002 Nov; 20(11):1067-8. PubMed ID: 12410239
    [No Abstract]   [Full Text] [Related]  

  • 26. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis inhibitors.
    Das M; Wakelee H
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S397-8. PubMed ID: 23160332
    [No Abstract]   [Full Text] [Related]  

  • 29. Cervical cancer therapy: current, future and anti-angiogensis targeted treatment.
    Willmott LJ; Monk BJ
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):895-903. PubMed ID: 19589029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tysabri's troubles return.
    Hoag H
    Nat Biotechnol; 2008 Oct; 26(10):1061. PubMed ID: 18846062
    [No Abstract]   [Full Text] [Related]  

  • 31. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
    Ademuyiwa FO; Miller KD
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor angiogenesis in melanoma.
    Marneros AG
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.
    D'Onofrio A; Gandolfi A
    Math Med Biol; 2009 Mar; 26(1):63-95. PubMed ID: 19033598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The year's new drugs.
    Graul AI; Prous JR
    Drug News Perspect; 2005; 18(1):21-36. PubMed ID: 15753973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergic rhinitis: market evolution.
    Clark MJ; Million RP
    Nat Rev Drug Discov; 2009 Apr; 8(4):271-2. PubMed ID: 19337269
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic antiangiogenic therapy: what goes around..
    Pulido JS; Itty S
    Br J Ophthalmol; 2009 Apr; 93(4):420-1. PubMed ID: 19321472
    [No Abstract]   [Full Text] [Related]  

  • 37. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
    Roy V; Perez EA
    Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commercializing clinical trials--risks and benefits of the CRO boom.
    Shuchman M
    N Engl J Med; 2007 Oct; 357(14):1365-8. PubMed ID: 17914036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.